US Stock MarketDetailed Quotes

CNSP CNS Pharmaceuticals

Watchlist

0.1289
-0.0011-0.85%

Close Jun 4 16:00 ET

1.53MMarket Cap-45P/E (TTM)

CNS Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Assets

Current assets

Cash, cash equivalents and short term investments

-84.05%815.23K

-94.54%548.72K

-87.06%909.55K

-52.23%4.28M

-58.92%5.11M

100.93%10.06M

-15.60%7.03M

30.11%8.96M

-Cash and cash equivalents

-84.05%815.23K

-94.54%548.72K

-87.06%909.55K

-52.23%4.28M

-58.92%5.11M

100.93%10.06M

-15.60%7.03M

30.11%8.96M

Current deferred assets

--0

--202.86K

----

--0

----

Other current assets

-57.78%786.05K

-66.54%839.59K

-31.12%1.15M

-26.52%1.79M

-18.80%1.86M

1.47%2.51M

-40.88%1.67M

-26.02%2.44M

Total current assets

-77.03%1.6M

-87.34%1.59M

-76.30%2.06M

-46.73%6.07M

-52.68%6.97M

68.03%12.56M

-22.01%8.7M

-17.91%11.4M

Non current assets

Net PPE

-1.82%4.31K

-12.91%4.93K

-59.28%3.47K

-69.17%3.38K

-65.56%4.39K

-64.84%5.66K

-51.38%8.52K

-47.50%10.97K

Non current deferred assets

----

0.00%334.14K

Non current prepaid assets

-87.38%55.3K

-78.30%104.75K

-55.84%262.73K

-46.48%377.2K

-44.67%438.13K

-48.07%482.81K

--594.9K

--704.79K

Total non current assets

-86.53%59.6K

-77.55%109.68K

-71.61%266.2K

-63.75%380.58K

-61.14%442.52K

-61.84%488.47K

166.61%937.56K

195.72%1.05M

Total assets

-77.60%1.66M

-86.97%1.7M

-75.84%2.33M

-48.17%6.45M

-53.28%7.41M

49.05%13.05M

-16.25%9.64M

-12.58%12.45M

Liabilities

Current liabilities

Payables

----

300.67%4.03M

627.39%3.57M

467.80%2.78M

----

-31.24%1.01M

-45.00%490.89K

-accounts payable

----

300.67%4.03M

627.39%3.57M

467.80%2.78M

----

-31.24%1.01M

-45.00%490.89K

Current accrued expenses

----

-5.94%260.14K

177.91%853.23K

----

-77.81%200K

-63.64%276.57K

Current debt and capital lease obligation

-26.28%213.1K

-26.63%300.81K

6.73%41.9K

6.39%166.4K

6.05%289.08K

5.72%409.97K

-12.04%39.26K

-11.93%156.4K

-Current debt

-26.28%213.1K

-26.63%300.81K

6.73%41.9K

6.39%166.4K

6.05%289.08K

5.72%409.97K

-12.04%39.26K

-11.93%156.4K

Current liabilities

55.28%6.09M

24.65%6.13M

226.99%4.07M

332.66%4M

266.87%3.92M

89.66%4.92M

-48.31%1.24M

-49.54%923.86K

Non current liabilities

Total non current liabilities

--0

Total liabilities

55.28%6.09M

24.65%6.13M

226.99%4.07M

332.66%4M

266.87%3.92M

89.66%4.92M

-48.31%1.24M

-49.54%923.86K

Shareholders'equity

Share capital

379.29%10.67K

284.29%6.21K

-89.49%4.21K

-89.66%4.14K

-94.44%2.23K

70.39%1.62K

45.78%40.03K

46.21%40.03K

-common stock

379.29%10.67K

284.29%6.21K

-89.49%4.21K

-89.66%4.14K

-94.44%2.23K

70.39%1.62K

45.78%40.03K

46.21%40.03K

-Preferred stock

--0

Retained earnings

-31.38%-73.11M

-37.17%-69.57M

-43.44%-64.19M

-44.36%-59.67M

-47.34%-55.65M

-43.10%-50.72M

-39.04%-44.75M

-45.68%-41.33M

Paid-in capital

16.12%68.67M

10.67%65.13M

17.59%62.45M

17.61%62.12M

12.58%59.14M

41.45%58.85M

28.71%53.11M

29.60%52.82M

Total stockholders'equity

-226.88%-4.43M

-154.50%-4.43M

-120.74%-1.74M

-78.70%2.45M

-76.41%3.49M

31.96%8.13M

-7.76%8.39M

-7.13%11.52M

Total equity

-226.88%-4.43M

-154.50%-4.43M

-120.74%-1.74M

-78.70%2.45M

-76.41%3.49M

31.96%8.13M

-7.76%8.39M

-7.13%11.52M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments	-84.05%815.23K	-94.54%548.72K	-94.54%548.72K	-87.06%909.55K	-52.23%4.28M	-58.92%5.11M	100.93%10.06M	100.93%10.06M	-15.60%7.03M	30.11%8.96M
-Cash and cash equivalents	-84.05%815.23K	-94.54%548.72K	-94.54%548.72K	-87.06%909.55K	-52.23%4.28M	-58.92%5.11M	100.93%10.06M	100.93%10.06M	-15.60%7.03M	30.11%8.96M
Current deferred assets	--0	--202.86K	--202.86K	----	----	----	--0	--0	----	----
Other current assets	-57.78%786.05K	-66.54%839.59K	-66.54%839.59K	-31.12%1.15M	-26.52%1.79M	-18.80%1.86M	1.47%2.51M	1.47%2.51M	-40.88%1.67M	-26.02%2.44M
Total current assets	-77.03%1.6M	-87.34%1.59M	-87.34%1.59M	-76.30%2.06M	-46.73%6.07M	-52.68%6.97M	68.03%12.56M	68.03%12.56M	-22.01%8.7M	-17.91%11.4M
Non current assets
Net PPE	-1.82%4.31K	-12.91%4.93K	-12.91%4.93K	-59.28%3.47K	-69.17%3.38K	-65.56%4.39K	-64.84%5.66K	-64.84%5.66K	-51.38%8.52K	-47.50%10.97K
Non current deferred assets	----	----	----	----	----	----	----	----	0.00%334.14K	0.00%334.14K
Non current prepaid assets	-87.38%55.3K	-78.30%104.75K	-78.30%104.75K	-55.84%262.73K	-46.48%377.2K	-44.67%438.13K	-48.07%482.81K	-48.07%482.81K	--594.9K	--704.79K
Total non current assets	-86.53%59.6K	-77.55%109.68K	-77.55%109.68K	-71.61%266.2K	-63.75%380.58K	-61.14%442.52K	-61.84%488.47K	-61.84%488.47K	166.61%937.56K	195.72%1.05M
Total assets	-77.60%1.66M	-86.97%1.7M	-86.97%1.7M	-75.84%2.33M	-48.17%6.45M	-53.28%7.41M	49.05%13.05M	49.05%13.05M	-16.25%9.64M	-12.58%12.45M
Liabilities
Current liabilities
Payables	----	----	----	300.67%4.03M	627.39%3.57M	467.80%2.78M	----	----	-31.24%1.01M	-45.00%490.89K
-accounts payable	----	----	----	300.67%4.03M	627.39%3.57M	467.80%2.78M	----	----	-31.24%1.01M	-45.00%490.89K
Current accrued expenses	----	----	----	----	-5.94%260.14K	177.91%853.23K	----	----	-77.81%200K	-63.64%276.57K
Current debt and capital lease obligation	-26.28%213.1K	-26.63%300.81K	-26.63%300.81K	6.73%41.9K	6.39%166.4K	6.05%289.08K	5.72%409.97K	5.72%409.97K	-12.04%39.26K	-11.93%156.4K
-Current debt	-26.28%213.1K	-26.63%300.81K	-26.63%300.81K	6.73%41.9K	6.39%166.4K	6.05%289.08K	5.72%409.97K	5.72%409.97K	-12.04%39.26K	-11.93%156.4K
Current liabilities	55.28%6.09M	24.65%6.13M	24.65%6.13M	226.99%4.07M	332.66%4M	266.87%3.92M	89.66%4.92M	89.66%4.92M	-48.31%1.24M	-49.54%923.86K
Non current liabilities
Total non current liabilities	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Total liabilities	55.28%6.09M	24.65%6.13M	24.65%6.13M	226.99%4.07M	332.66%4M	266.87%3.92M	89.66%4.92M	89.66%4.92M	-48.31%1.24M	-49.54%923.86K
Shareholders'equity
Share capital	379.29%10.67K	284.29%6.21K	284.29%6.21K	-89.49%4.21K	-89.66%4.14K	-94.44%2.23K	70.39%1.62K	70.39%1.62K	45.78%40.03K	46.21%40.03K
-common stock	379.29%10.67K	284.29%6.21K	284.29%6.21K	-89.49%4.21K	-89.66%4.14K	-94.44%2.23K	70.39%1.62K	70.39%1.62K	45.78%40.03K	46.21%40.03K
-Preferred stock	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Retained earnings	-31.38%-73.11M	-37.17%-69.57M	-37.17%-69.57M	-43.44%-64.19M	-44.36%-59.67M	-47.34%-55.65M	-43.10%-50.72M	-43.10%-50.72M	-39.04%-44.75M	-45.68%-41.33M
Paid-in capital	16.12%68.67M	10.67%65.13M	10.67%65.13M	17.59%62.45M	17.61%62.12M	12.58%59.14M	41.45%58.85M	41.45%58.85M	28.71%53.11M	29.60%52.82M
Total stockholders'equity	-226.88%-4.43M	-154.50%-4.43M	-154.50%-4.43M	-120.74%-1.74M	-78.70%2.45M	-76.41%3.49M	31.96%8.13M	31.96%8.13M	-7.76%8.39M	-7.13%11.52M
Total equity	-226.88%-4.43M	-154.50%-4.43M	-154.50%-4.43M	-120.74%-1.74M	-78.70%2.45M	-76.41%3.49M	31.96%8.13M	31.96%8.13M	-7.76%8.39M	-7.13%11.52M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall